Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas
J Dermatolog Treat
.
2022 Mar;33(2):1163-1164.
doi: 10.1080/09546634.2020.1781042.
Epub 2020 Jul 9.
Authors
Chidubem A V Okeke
1
,
William D Shipman
2
,
Jessica D Perry
1
,
Michelle L Kerns
3
,
Ginette A Okoye
4
,
Angel S Byrd
4
Affiliations
1
Howard University College of Medicine, Washington, DC, USA.
2
Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program, New York, NY, USA.
3
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
4
Department of Dermatology, Howard University College of Medicine, Washington, DC, USA.
PMID:
32643464
DOI:
10.1080/09546634.2020.1781042
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Hidradenitis Suppurativa* / diagnosis
Humans
Pandemics